A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients

Harris, MarianneCôté, HélèneOchoa, ClaudiaAllavena, ClotildeNegredo, EugeniaThorne, AnonaCahn, PedroRaffi, FrancoisClotet, BonaventuraSinger, JoelMontaner, JulioThe CTN 177 Study Team2024-05-232024-05-232009-03https://doi.org/10.1097/qai.0b013e3181938fc9https://repositorio.huesped.org.ar/handle/123456789/1313Fil: Ochoa C. Fundación Huésped, Buenos Aires; ArgentinaFil: Cahn P. Fundación Huésped, Buenos Aires; ArgentinaFil: Zala C. Fundación Huésped, Buenos Aires; Argentinaapplication/pdfopenAccessHIVA Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected PatientsArticulo